Management Impact of Metachronous Oligometastatic Disease Identified on 18F-Fluciclovine (Axumin™) PET/CT in Biochemically Recurrent Prostate Cancer

被引：0
|
作者：
Redmond-Craig Anderson
Erik M. Velez
Hossein Jadvar
机构：
[1] University of Southern California,Division of Nuclear Medicine, Department of Radiology, Keck School of Medicine
来源：
Molecular Imaging and Biology | 2022年 / 24卷
关键词：
Oligometastatic; Prostate; Cancer; Fluciclovine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：920 / 927
页数：7
相关论文
共 50 条
  • [21] Cavernosal Metastasis From Prostate Cancer on 18F-Fluciclovine PET/CT
    Nguyen, Ba D.
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (10) : E449 - E450
  • [22] Best Practices for 18F-Fluciclovine PET/CT Imaging of Recurrent Prostate Cancer: A Guide for Technologists
    Tade, Funmilayo I.
    Sajdak, Rebecca A.
    Gabriel, Mehdat
    Wagner, Robert H.
    Savir-Baruch, Bital
    JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2019, 47 (04) : 282 - 287
  • [23] UK guidelines on 18F-fluciclovine PET/CT in prostate cancer imaging
    Afaq, Asim
    Gleeson, Fergus
    Scarsbrook, Andrew
    Bradley, Kevin
    Subesinghe, Manil
    Macpherson, Ruth
    Haroon, Athar
    Patel, Neel
    Chua, Sue
    Wong, Wai-Lup
    Vinjamuri, Sobhan
    Warbey, Victoria S.
    Cook, Gary J.
    Bomanji, Jamshed
    NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (07) : 662 - 674
  • [24] Comparison of 68Ga-PSMA-11 PET/CT and 18F-Fluciclovine PET/CT in recurrent Prostate Cancer
    Ceci, F.
    Polverari, G.
    Gartmann, J.
    Fendler, W.
    Eiber, M.
    Herrmann, K.
    Czernin, J.
    Calais, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S150 - S150
  • [25] Comparison of 18F-Fluciclovine and 18F-Flurocholine PET/CT diagnostic performance in recurrent prostate cancer patients
    Ferrari, C.
    Nappi, A. G.
    Lavelli, V.
    Mammucci, P.
    Merenda, N. C.
    Rubini, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S445 - S446
  • [26] Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on 18F-Fluciclovine PET/CT Guidance
    Abiodun-Ojo, Olayinka A.
    Jani, Ashesh B.
    Akintayo, Akinyemi A.
    Akin-Akintayo, Oladunni O.
    Odewole, Oluwaseun A.
    Tade, Funmilayo I.
    Joshi, Shreyas S.
    Master, Viraj A.
    Fielder, Bridget
    Halkar, Raghuveer K.
    Zhang, Chao
    Goyal, Subir
    Goodman, Mark M.
    Schuster, David M.
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (08) : 1089 - 1096
  • [27] 18F-Fluciclovine Uptake by an Incidentally Detected Hepatocellular Carcinoma in a Case of Biochemically Recurrent Prostate Cancer
    Sannananja, Bhagya
    Shah, Hardik Uresh
    Behnia, Fatemeh
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (09) : 692 - 693
  • [28] Update on 18F-Fluciclovine PET for Prostate Cancer Imaging
    Parent, Ephraim E.
    Schuster, David M.
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (05) : 733 - 739
  • [29] Impact of 18F-fluciclovine PET/CT on Clinical Management of Patients with Recurrent Prostate Cancer: Results from the Phase 3 FALCON Trial
    Teoh, E.
    Bottomley, D.
    Scarsbrook, A.
    Payne, H.
    Afaq, A.
    Bomanji, J.
    van As, N.
    Chua, S.
    Hoskin, P.
    Chambers, A.
    Cook, G. J.
    Warbey, V. S.
    Chau, A.
    Ward, P.
    Miller, M. P.
    Stevens, D. J.
    Wilson, L.
    Gleeson, F. V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (05): : 1316 - 1317
  • [30] 18F-fluciclovine PET or PSMA PET for prostate cancer imaging?
    Baris Turkbey
    Peter L. Choyke
    Nature Reviews Urology, 2020, 17 : 9 - 10
12345